Liquidity
Weak0
How the figure is assessed
Current assets divided by current liabilities. Below 1.0 is weak, 1.0–1.5 needs attention and 1.5 or more is strong.
Org. no. 895 238 902 · Private limited company (AS) · Active · Stakkevollvegen 51, 9010, TROMSØ · TROMSØ · 21.100 – Manufacture of basic pharmaceutical products
SCANDIDERMA AS is a private limited company (as) registered in TROMSØ since 2010. The organisation number is 895 238 902. The latest submitted annual accounts are for 2025.
Source: The Brønnøysund Register Centre · Last updated 22 November 2026 at 06:50
Quick overview
Based on the latest submitted annual accounts (2025) and registry data.
0
Current assets divided by current liabilities. Below 1.0 is weak, 1.0–1.5 needs attention and 1.5 or more is strong.
90.1 %
Operating profit divided by operating revenue. Below 0% is weak, 0–10% needs attention and 10% or more is strong.
-15,646,672.7 %
Equity divided by assets. Below 10% is weak, 10–30% needs attention and 30% or more is strong.
Calculated by us
⚠ Negative equity
Based on status, solvency, liquidity, profitability, trend and how recent the accounts are. Public register data only.
This is an indicative assessment, not a credit rating. It does not replace your own due diligence before entering into an agreement.
Proffi+
Calculating …
Indicative model estimate based on public accounting figures and typical industry multiples. Not an appraisal, a valuation or investment advice.
Development
Revenue and profit
RevenueResult
Development
Solvency and profitability (%)
SolidityProfitability
Registry data
Addresses
Industry
Manufacture of basic pharmaceutical products(main industry)
C Manufacturing › 21 Manufacture of basic pharmaceutical products and pharmaceutical preparations › 21.1 Manufacture of basic pharmaceutical products › 21.10 Manufacture of basic pharmaceutical products
See the industry: largest companies and key figures →Inkluderer: Omfatter produksjon av aktive, medisinske stoffer som brukes til produksjon av medikamenter: antibiotika, basisvitaminer, salicyl- og O-acetylsalicylsyre mv. og bearbeiding av blod Inkluderer også: Omfatter også produksjon av kjemisk rent sukker og bearbeiding av kjertler og produksjon av ekstrakter av kjertler mv.
Institutional sector code: Private aksjeselskaper mv. (2100)
Utvikle, produsere og selge kosmetiske ingredienser, samt engasjere seg i det som står i naturlig sammenheng med dette. Selskapet skal også kunne delta i andre selskaper med lignende økonomisk formål.
Registry status
Experiences
Loading reviews …
You must sign in with a verified email to write a review.
Financial overview
Fiscal year 2025 · Amounts in NOK
Data basis
3 stored years
0
Current assets divided by current liabilities. Below 1.0 is weak, 1.0–1.5 needs attention and 1.5 or more is strong.
90.1 %
Operating profit divided by operating revenue. Below 0% is weak, 0–10% needs attention and 10% or more is strong.
-15,646,672.7 %
Equity divided by assets. Below 10% is weak, 10–30% needs attention and 30% or more is strong.
Only reported amounts from the Register of Company Accounts
| Accounting item | 2025 | 2024 | 2023 | Development |
|---|---|---|---|---|
| Operating revenue | 926,566 | 1,255,666 | 1,053,429 | |
| Operating profit | 834,833 | 1,093,426 | -216,163 | |
| Profit before tax | 834,824 | 1,207,592 | -216,206 | |
| Net result | 834,824 | 1,207,592 | -216,206 | |
| Total assets | 33 | 416,343 | 409,850 | |
| Equity | -5,163,402 | -5,998,226 | -7,205,818 | |
| Liabilities | 5,163,435 | 6,414,570 | 7,615,668 |
Graphical analysis
Amounts in NOK
Calculated by us, in percent
Balance sheet in NOK
Register of Company Accounts
Period 2025-01-01 to 2025-12-31. Currency NOK. Audited annual accounts. Virksomheten har fravalgt revisjon.
| Total operating revenue | 926,566 NOK |
|---|---|
| Total operating expenses | 91,734 NOK |
| Operating profit | 834,833 NOK |
| Total financial income | 0 NOK |
| Total financial expenses | 9 NOK |
| Net financial items | -9 NOK |
| Profit before tax | 834,824 NOK |
| Net result | 834,824 NOK |
| Total fixed assets | 0 NOK |
|---|---|
| Total current assets | 33 NOK |
| Total assets | 33 NOK |
| Paid-in equity | 6,414,688 NOK |
|---|---|
| Retained earnings | -11,578,090 NOK |
| Total equity | -5,163,402 NOK |
| Current liabilities | 1,419,234 NOK |
| Total debt | 5,163,435 NOK |
| Total equity and liabilities | 33 NOK |
Register of Company Accounts
Period 2024-01-01 to 2024-12-31. Currency NOK. Audited annual accounts. Virksomheten har fravalgt revisjon.
| Total operating revenue | 1,255,666 NOK |
|---|---|
| Total operating expenses | 162,239 NOK |
| Operating profit | 1,093,426 NOK |
| Total financial income | 114,500 NOK |
| Total financial expenses | 334 NOK |
| Net financial items | 114,166 NOK |
| Profit before tax | 1,207,592 NOK |
| Net result | 1,207,592 NOK |
| Total fixed assets | 383,125 NOK |
|---|---|
| Total current assets | 33,218 NOK |
| Total assets | 416,343 NOK |
| Paid-in equity | 6,414,688 NOK |
|---|---|
| Retained earnings | -12,412,914 NOK |
| Total equity | -5,998,226 NOK |
| Current liabilities | 1,360,977 NOK |
| Long-term liabilities | 5,053,592 NOK |
| Total debt | 6,414,570 NOK |
| Total equity and liabilities | 416,344 NOK |
Register of Company Accounts
Period 2023-01-01 to 2023-12-31. Currency NOK. Audited annual accounts. Virksomheten har fravalgt revisjon.
| Total operating revenue | 1,053,429 NOK |
|---|---|
| Total operating expenses | 1,269,592 NOK |
| Operating profit | -216,163 NOK |
| Total financial income | 0 NOK |
| Total financial expenses | 43 NOK |
| Net financial items | -43 NOK |
| Profit before tax | -216,206 NOK |
| Net result | -216,206 NOK |
| Total fixed assets | 383,125 NOK |
|---|---|
| Total current assets | 26,725 NOK |
| Total assets | 409,850 NOK |
| Paid-in equity | 6,414,688 NOK |
|---|---|
| Retained earnings | -13,620,507 NOK |
| Total equity | -7,205,818 NOK |
| Current liabilities | 2,567,376 NOK |
| Long-term liabilities | 5,048,292 NOK |
| Total debt | 7,615,668 NOK |
| Total equity and liabilities | 409,850 NOK |
Source: Register of Company Accounts, Brønnøysund Register Centre. Figures are shown as submitted, and historical years are never overwritten by newer submissions.
Calculated by us
| Key figures | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue growthChange in total operating revenue from the previous fiscal year. | -26.2 % | 19.2 % | – |
| Operating marginOperating profit divided by total operating revenue. | 90.1 % | 87.1 % | -20.5 % |
| Profit marginOrdinary profit before tax divided by total operating revenue. | 90.1 % | 96.2 % | -20.5 % |
| Equity ratioTotal equity divided by total assets. | -15,646,672.7 % | -1,440.7 % | -1,758.2 % |
| Current ratioTotal current assets divided by total current liabilities. | 0 | 0.02 | 0.01 |
| Debt ratioTotal liabilities divided by total equity. | -1 | -1.07 | -1.06 |
| Return on assetsOrdinary profit before tax plus financial expenses, divided by total assets. | 2,529,797 % | 290.1 % | -52.7 % |
| Return on equityNet profit divided by total equity. | -16.2 % | -20.1 % | 3 % |
About the calculation
The key figures are calculated by us (formula version v1) from public accounts in the Register of Company Accounts. A figure is only calculated when all input values exist and the denominator is not zero. The figures are not a credit assessment.
Registry data
Source: The Brønnøysund Register Centre. We only show name and role as published by the register – never date of birth or private address.
Structure
Overview
SCANDIDERMA AS
TROMSØ
Registry data
| Name | Org. no. | Place | Employees |
|---|---|---|---|
| SCANDIDERMA ASManufacture of basic pharmaceutical products | 995 266 008 | TROMSØ | – |
This has not been registered yet. We never show made-up information.
Services and products
The company has not added any services yet.
Public approvals
Not in the Norwegian Building Authority's central approval register.
Public contracts
No notices found in TED where the company is a supplier or contracting authority.
Registered changes
We show changes from the Brønnøysund Register Centre's change log from the next registered change.
Documents
Certificates of registration and other documents require a separate agreement with a document provider.
Transparency
Company information
Brønnøysund Register Centre · Public register
Last retrieved 22 November 2026 at 06:50
Open official sourceRoles
Brønnøysund Register Centre · Public register
Last retrieved 22 November 2026 at 06:50
Open official sourceAccounts and key figures
Register of Company Accounts · Public register
Last retrieved 22 November 2026 at 06:50
Open official sourceAddress (verified)
Norwegian Mapping Authority – Geonorge address API · Public register
Last retrieved 22 November 2026 at 06:50
Open official sourceCentral approval
Norwegian Building Authority (DiBK) · No approval found
Last retrieved 22 November 2026 at 06:50
Open official sourceIndustry standard (SN2007)
Statistics Norway – KLASS · Official standard
Last retrieved 22 November 2026 at 06:50
Open official sourcePublic registry data is updated periodically and cannot be changed by the company. Calculated figures are marked “Calculated by us”.
Report an errorSource
Public registry fields on this page come from the Central Coordinating Register and cannot be changed by the company. Self-reported content is marked separately.
Read about the data sourcesTalk to Proffi
Leave your contact details and an adviser will explain how segmentation, company profiles and supplier search can support your business.